Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Operating Cash Flow Growth
-30.78%
Quarterly · Period ending:
LCTX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-30.78%period ending
Latest reported-30.78%period ending
LCTX Quarterly Cash from Operations YoY % (-300.00% → -30.78%)
Year-over-year change
High-resolution chart · PNG
LCTX operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -30.7817% | |
| -65.3295% | |
| 23.1327% | |
| 37.5151% | |
| -7.0131% | |
| 15.511% | |
| -5.4328% | |
| -14.8898% | |
| 17.4218% | |
| 48.559% | |
| 27.5081% | |
| 8.0839% | |
| 11.2433% | |
| -151.324% | |
| -41.3758% | |
| -13.0363% | |
| -30.3914% | |
| 395.0431% | |
| -4.1127% | |
| -0.0206% | |
| -27.766% | |
| -47.7119% | |
| -2.1365% | |
| 34.8784% | |
| 56.1498% | |
| 46.0382% | |
| 4.9725% | |
| -1.5139% | |
| -30.6351% | |
| 9.9052% | |
| -2.4141% | |
| 4.5437% | |
| 18.3493% | |
| -27.6612% | |
| 35.8902% | |
| 13.8418% | |
| 11.546% | |
| 43.4221% | |
| 36.5312% | |
| 22.8873% | |
| -2.7974% | |
| -57.8265% | |
| -53.0923% | |
| -34.2935% | |
| 7.5227% | |
| 12.4401% | |
| -5.6017% | |
| -34.1672% | |
| -44.7961% | |
| -47.5041% | |
| -72.6741% | |
| -28.1043% | |
| -88.0757% | |
| -22.8225% | |
| -38.9492% | |
| -39.3105% | |
| -41.5772% | |
| -58.4762% | |
| -29.4736% | |
| -79.8686% | |
| -61.5597% | |
| -194.1052% | |
| -228.4301% | |
| -37.1123% | |
| -85.9082% | |
| -19.5749% | |
| -65.2522% | |
| -356.895% | |
| -84.9497% | |
| -279.5703% | |
| -44.3388% | |
| -107.8934% | |
| -43.7652% | |
| 29.2464% | |
| -86.7618% | |
| 35.4955% | |
| -290.1884% | |
| 48.7135% | |
| -154.4073% | |
| 63.9923% | |
| 79.7598% | |
| -13.0134% | |
| 276.1272% | |
| -262.5154% | |
| -14.534% | |
| 14.3436% | |
| 57.342% | |
| -134.3192% | |
| -141.8335% | |
| -37.16% | |
| 9.4479% | |
| 214.2487% | |
| 67.0862% | |
| 15.6874% | |
| -80.5488% | |
| 57.973% | |
| 39.8123% | |
| 34.2513% | |
| 66.9154% | |
| 4.7569% |